Clinical Trial Update: Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing ticagrelor to prasugrel in patients with acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Acute Coronary Syndrome (ACS) | Phase 4 | Status: COMPLETED